Summary
The Huberman Lab Podcast features an episode with Dr. Matthew Johnson, a professor of psychiatry at Johns Hopkins School of Medicine, discussing the effects of different types of drugs on human behavior, particularly psychedelics. The conversation covers microdosing and macrodosing, and Dr. Johnson walks through what an experiment of a patient taking psychedelics for the treatment of depression looks like in his laboratory from start to finish. The podcast also explores the therapeutic effects of psychedelics on depression and the value of going into a restricted perceptual bubble. The speakers discuss the potential benefits and risks of using psychedelics for therapeutic purposes, cautioning against using psychedelics as a first-line treatment for mental health conditions. They also touch on the ongoing research on the medical benefits of psychedelics, particularly in treating depression and PTSD, and the potential use of psychedelics in treating neurological injuries, such as traumatic brain injury. The conversation highlights the emerging psychedelic startup industry and the potential for both positive and negative outcomes from increased investment in this area.
